MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence

Prostate

Volumn 76, Issue 10, 2016, Pages 869-884

  Nam, Robert K ^a   Benatar, Tania ^a   Wallis, Christopher J D ^a   Amemiya, Yutaka ^a   Yang, Wenyi ^a   Garbens, Alaina ^a   Naeim, Magda ^b   Sherman, Christopher ^b   Sugar, Linda ^b   Seth, Arun ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b Canada   (Canada)

Author keywords

biomarkers; cadherins; carcinogenesis; epithelial mesenchymal transition; microRNAs; transcriptome

Indexed keywords

MICRORNA; PROTEIN MIR 301A; PROTEIN P63; PROTEIN ZEB2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ZEB1; TRANSCRIPTOME; UNCLASSIFIED DRUG; UVOMORULIN; CADHERIN; MIRN205 MICRORNA, HUMAN; MIRN301 MICRORNA, HUMAN; TP63 PROTEIN, HUMAN; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN; ZEB1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BIOCHEMICAL RECURRENCE; CANCER PROGNOSIS; CANCER RECURRENCE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROSTATECTOMY; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN TARGETING; REGULATORY MECHANISM; RNA SEQUENCE; UPREGULATION; WESTERN BLOTTING; CHEMISTRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; PHYSIOLOGY; PROSTATIC NEOPLASMS; SEQUENCE ANALYSIS; TUMOR CELL LINE; TUMOR RECURRENCE;

AGED; BIOMARKERS, TUMOR; CADHERINS; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATECTOMY; PROSTATIC NEOPLASMS; SEQUENCE ANALYSIS, RNA; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; ZINC FINGER E-BOX-BINDING HOMEOBOX 1;

EID: 84961279539     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.23177     Document Type: Article

References (33)

1. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. MicroRNA expression profiles classify human cancers. Nature 2005; 435(7043):834–838.
2. Witte JS. Prostate cancer genomics: Towards a new understanding. Nat Rev Genet 2009; 10(2):77–82.
3. Calin GA, Croce CM. MicroRNA-cancer connection: The beginning of a new tale. Cancer Res 2006; 66(15):7390–7394.
4. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009; 10(10):704–714.
5. Garzon R, Calin GA, Croce CM. MicroRNAs in Cancer. Annu Rev Med 2009; 60:167–179.
6. Lujambio A, Lowe SW. The microcosmos of cancer. Nature 2012; 482(7385):347–355.
7. Nam RK, Amemiya Y, Benatar T, Wallis CJ, Stojcic-Bendavid J, Bacopulos S, Sherman C, Sugar L, Naeim M, Yang W, Zhang A, Klotz LH, Narod SA, Seth A. Identification and validation of a five MicroRNA signature predictive of prostate cancer recurrence and metastasis: A cohort study. J Cancer 2015; 6(11):1160–1171.
8. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10(5):593–601.
9. Tran MN, Choi W, Wszolek MF, Navai N, Lee IL, Nitti G, Wen S, Flores ER, Siefker-Radtke A, Czerniak B, Dinney C, Barton M, McConkey DJ. The p63 protein isoform DeltaNp63alpha inhibits epithelial-mesenchymal transition in human bladder cancer cells: Role of MIR-205. J Biol Chem 2013; 288(5):3275–3288.
10. Tsai JH, Yang J. Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev 2013; 27(20):2192–2206.
11. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000; 2(2):76–83.
12. Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM, Farace MG. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 2005; 334(4):1351–1358.
13. Vandewalle C, Comijn J, De Craene B, Vermassen P, Bruyneel E, Andersen H, Tulchinsky E, Van Roy F, Berx G. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell–cell junctions. Nucleic Acids Res 2005; 33(20):6566–6578.
14. Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P. American Urological A. Prostate specific antigen best practice statement: 2009 update. J Urol 2013; 189(1 Suppl):S2–S11.
15. Bandres E, Cubedo E, Agirre X, Malumbres R, Zarate R, Ramirez N, Abajo A, Navarro A, Moreno I, Monzo M, Garcia-Foncillas J. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 2006; 5:29.
16. Guo J, Miao Y, Xiao B, Huan R, Jiang Z, Meng D, Wang Y. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 2009; 24(4):652–657.
17. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65(16):7065–7070.
18. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T, Shimotohno K. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006; 25(17):2537–2545.
19. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T, Takahashi T. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004; 64(11):3753–3756.
20. Chen Z, Chen LY, Dai HY, Wang P, Gao S, Wang K. MiR-301a promotes pancreatic cancer cell proliferation by directly inhibiting Bim expression. J Cell Biochem 2012; 113(10):3229–3235.
21. Liu L, Nie J, Chen L, Dong G, Du X, Wu X, Tang Y, Han W. The oncogenic role of microRNA-130a/301a/454 in human colorectal cancer via targeting Smad4 expression. PLoS ONE 2013; 8(2):e55532.
22. Lu Z, Li Y, Takwi A, Li B, Zhang J, Conklin DJ, Young KH, Martin R, Li Y. MiR-301a as an NF-kappaB activator in pancreatic cancer cells. EMBO J 2011; 30(1):57–67.
23. Shi W, Gerster K, Alajez NM, Tsang J, Waldron L, Pintilie M, Hui AB, Sykes J, P'ng C, Miller N, McCready D, Fyles A, Liu FF. MicroRNA-301 mediates proliferation and invasion in human breast cancer. Cancer Res 2011; 71(8):2926–2937.
24. Wang M, Li C, Yu B, Su L, Li J, Ju J, Yu Y, Gu Q, Zhu Z, Liu B. Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer. J Gastroenterol 2013; 48(9):1023–1033.
25. Xu XD, He XJ, Tao HQ, Zhang W, Wang YY, Ye ZY, Zhao ZS. Abnormal expression of miR-301a in gastric cancer associated with progression and poor prognosis. J Surg Oncol 2013; 108(3):197–202.
26. Zhou P, Jiang W, Wu L, Chang R, Wu K, Wang Z. MiR-301a is a candidate oncogene that targets the homeobox gene Gax in human hepatocellular carcinoma. Dig Dis Sci 2012; 57(5):1171–1180.
27. Thompson IM, Valicenti RK, Albertsen P, et al. Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline. J Urol 2013; 190:441–449.
28. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, Tabin C, Sharpe A, Caput D, Crum C, McKeon F. P63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999; 398(6729):714–718.
29. Tucci P, Agostini M, Grespi F, Markert EK, Terrinoni A, Vousden KH, Muller PA, Dotsch V, Kehrloesser S, Sayan BS, Giaccone G, Lowe SW, Takahashi N, Vandenabeele P, Knight RA, Levine AJ, Melino G. Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer. Proc Natl Acad Sci USA 2012; 109(38):15312–15317.
30. Jacob S, Nayak S, Fernandes G, Barai RS, Menon S, Chaudhari UK, Kholkute SD, Sachdeva G. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer. Endocr Relat Cancer 2014; 21(3):473–486.
31. Tsuchiyama K, Ito H, Taga M, Naganuma S, Oshinoya Y, Nagano K, Yokoyama O, Itoh H. Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer. Prostate 2013; 73(8):827–834.
32. Walter BA, Valera VA, Pinto PA, Merino MJ. Comprehensive microRNA Profiling of Prostate Cancer. J Cancer 2013; 4(5):350–357.
33. Haffner MC, Mosbruger T, Esopi DM, Fedor H, Heaphy CM, Walker DA, Adejola N, Gurel M, Hicks J, Meeker AK, Halushka MK, Simons JW, Isaacs WB, De Marzo AM, Nelson WG, Yegnasubramanian S. Tracking the clonal origin of lethal prostate cancer. J Clin Invest 2013; 123(11):4918–4922.